Administrative Core
行政核心
基本信息
- 批准号:10408086
- 负责人:
- 金额:$ 9.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:Cancer CenterClinical Cancer CenterClinical ResearchClinical TrialsCollaborationsCommunicationComprehensive Cancer CenterConduct Clinical TrialsDreamsEnsureFeedbackFundingGoalsGrantGroup MeetingsHumanImmune System DiseasesIndividualMalignant NeoplasmsMalignant neoplasm of gastrointestinal tractMalignant neoplasm of pancreasManuscriptsMonitorOffice of Administrative ManagementPreparationPrincipal InvestigatorProblem SolvingProgram Research Project GrantsReportingResearch PersonnelResearch Project GrantsResourcesRoleSeriesSiteSupervisionUnited States National Institutes of HealthUniversitiesUpdateclinical careexperiencemeetingsmemberpancreatic cancer patientspre-clinicalprogramssuccesstranslational clinical trialtumor immunology
项目摘要
Administrative Core Summary/Abstract
The overall goal of the Administrative Core is to maximize integration of all projects and cores, and
collaborations among Program Investigators and Core leaders. This Core is essential for coordinating
the scientific, financial, organizational, and monitoring activities, and facilitating inter-project interactions
of this multi-project grant to maximize the success of the overall multi-project research program. The
Core will be led by Dr. Elizabeth Jaffee, who has extensive experience overseeing scientific programs
at the Sidney Kimmel Cancer Center at Johns Hopkins, as well as a number of multi-project NIH funded
programs. Dr. Jaffee recently served as the Team Leader for a multi-site, multiple principal investigator
grant through Stand Up To Cancer. Dr. Daniel Laheru will serve as co-leader of this Core. Dr. Laheru
brings many years of experience conducting clinical trials in pancreatic cancer and serves as the co-
director of the Gastrointestinal Cancer program and co-director of the Skip Viragh Pancreatic Cancer
Center for Clinical Research and Clinical Care.
The specific aims are to: 1) Provide organizational and administrative management to insure success
of all projects and cores within the program; and 2) Facilitate scientific collaborations and program
oversight through the coordination of scientific and advisory board meetings for the investigators in this
program.
Drs. Jaffee and Laheru will monitor progress of all Projects and Cores, identify challenges or hurdles,
and assist with problem solving. The Administrative Assistant to Drs. Jaffee and Laheru, will be
responsible for oversight of the distribution and usage of funding provided to the individual programs
and Cores. She will also provide monthly financial reports for all projects and cores within the program,
assist investigators with non-competitive renewal applications, and provide support for manuscript
preparation and submission.
Drs. Jaffee and Laheru will convene weekly scientific meetings for all members of the Program Project,
and monthly meetings of Project and Core Leaders to ensure adequate communication between and
integration of all Project and Core teams. There will also be quarterly meetings with the internal
advisory board to monitor and provide input on the group’s scientific progress. In addition, there will be
an annual one-day scientific retreat to include all investigators and the internal and external scientific
advisors. A closed advisory board meeting will be held at the conclusion of the retreat for the advisors
to provide objective feedback to the program investigators.
行政核心摘要/摘要
行政核心的总体目标是最大化所有项目和核心的集成,以及
计划调查员和核心领导者之间的合作。该核心对于协调至关重要
科学,财务,组织和监视活动以及支持项目间互动
这项多项目赠款以最大化整体多项目研究计划的成功。
核心将由伊丽莎白·贾菲(Elizabeth Jaffee)博士领导,他在监督科学计划方面拥有丰富的经验
在约翰·霍普金斯(Johns Hopkins)的西德尼·金梅尔(Sidney Kimmel)癌症中心,以及许多多项目的NIH资助
程序。 Jaffee博士最近曾担任多站点,多个首席研究员的团队负责人
通过站立癌症来授予。 Daniel Laheru博士将担任该核心的共同领导者。 Laheru博士
带来了在胰腺癌进行临床试验的多年经验,并作为共同
胃肠道癌症计划的主任和Skip Viragh胰腺癌的联合导演
临床研究与临床护理中心。
具体目的是:1)提供组织和行政管理以确保成功
该计划中的所有项目和核心; 2)促进科学合作和计划
通过为调查人员协调科学和顾问委员会会议的监督
程序。
博士。贾菲(Jaffee)和莱厄(Laheru)将监视所有项目和核心的进度,确定挑战或障碍,
并协助解决问题。 Drs的行政助理。贾菲(Jaffee)和莱厄(Laheru)将会
负责监督提供给单个计划的资金的分配和使用
和核心。她还将为计划中的所有项目和核心提供每月财务报告,
协助调查人员进行非竞争性更新应用,并为手稿提供支持
准备和提交。
博士。 Jaffee和Laheru将为该计划项目的所有成员提供便利的每周科学会议,
以及项目和核心领导者的每月会议,以确保与
所有项目和核心团队的集成。还将与内部举行季度会议
咨询委员会监视和提供有关该小组科学进步的意见。另外,会有
一年一度的一日科学务虚会,包括所有研究人员以及内部和外部科学
顾问。顾问务虚会结束时将举行封闭的顾问委员会会议
向计划调查人员提供客观的反馈。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELIZABETH M. JAFFEE其他文献
ELIZABETH M. JAFFEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELIZABETH M. JAFFEE', 18)}}的其他基金
Transforming Human Pancreatic Cancer Into An Immunologic Disease
将人类胰腺癌转变为免疫疾病
- 批准号:
10408080 - 财政年份:2021
- 资助金额:
$ 9.58万 - 项目类别:
Integration of neo-antigen vaccines and immune checkpoint therapy
新抗原疫苗与免疫检查点疗法的整合
- 批准号:
10408081 - 财政年份:2021
- 资助金额:
$ 9.58万 - 项目类别:
Transforming Human Pancreatic Cancer Into An Immunologic Disease
将人类胰腺癌转变为免疫疾病
- 批准号:
10661794 - 财政年份:2021
- 资助金额:
$ 9.58万 - 项目类别:
Integration of neo-antigen vaccines and immune checkpoint therapy
新抗原疫苗与免疫检查点疗法的整合
- 批准号:
10661795 - 财政年份:2021
- 资助金额:
$ 9.58万 - 项目类别:
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
利用新辅助平台针对胰腺癌免疫抑制肿瘤微环境的临床试验
- 批准号:
10407582 - 财政年份:2015
- 资助金额:
$ 9.58万 - 项目类别:
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
利用新辅助平台针对胰腺癌免疫抑制肿瘤微环境的临床试验
- 批准号:
10654572 - 财政年份:2015
- 资助金额:
$ 9.58万 - 项目类别:
Reprogramming the pancreatic tumor microenvironment with immunotherapy
用免疫疗法重新编程胰腺肿瘤微环境
- 批准号:
9306033 - 财政年份:2015
- 资助金额:
$ 9.58万 - 项目类别:
Reprogramming the pancreatic tumor microenvironment with immunotherapy
用免疫疗法重新编程胰腺肿瘤微环境
- 批准号:
8941804 - 财政年份:2015
- 资助金额:
$ 9.58万 - 项目类别:
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
(PQB-3) 驱动基因诱导的胰腺癌发展中的炎症
- 批准号:
9042316 - 财政年份:2014
- 资助金额:
$ 9.58万 - 项目类别:
相似海外基金
Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
- 批准号:
10752046 - 财政年份:2024
- 资助金额:
$ 9.58万 - 项目类别:
Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
- 批准号:
10748859 - 财政年份:2024
- 资助金额:
$ 9.58万 - 项目类别:
Increasing access to cancer trials in Minnesota (InACT-MN)
增加明尼苏达州癌症试验的机会 (InACT-MN)
- 批准号:
10636408 - 财政年份:2023
- 资助金额:
$ 9.58万 - 项目类别:
Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations
在农村和城市人群中实施纽约大学电子患者就诊评估 (ePVA) 来评估头颈癌
- 批准号:
10715478 - 财政年份:2023
- 资助金额:
$ 9.58万 - 项目类别: